Johnson & Johnson (NYSE:JNJ) Q2 2023 Earnings Call Transcript July 20, 2023 Johnson & Johnson beats earnings expectations. Reported EPS is $2.8, expectations were $2.62. Operator: Good morning, and welcome to Johnson & Johnson’s Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. […]
By Jef Feeley Johnson & Johnson was ordered to pay $18.8 million to a California man who blamed the company’s talcum-based powders for giving him cancer in the company’s first trial in almost two years over accusations it hid the health risks of its iconic baby powder.